Challenging results from mTOR inhibitors in metastatic clear cell renal cancer
26 Feb 2015
Challenging results from mTOR inhibitors in metastatic clear cell renal cancer
Efficacy, tolerability and quality of life in metastatic renal cell carcinoma: Welcome and introduction
mRCC: Real-world experience: achieving efficacy beyond clinical trials
mRCC: Are we doing all we can to manage adverse events?
mRCC: Understanding the patient's perspective
mRCC: Panel discussion
mRCC: Closing remarks
A short tour of the p-medicine Biovista Correlation Viewer Tool
A short tour of the p-medicine ObTiMA Tool
ecancermedicalscience editor's choice for January 2015
ecancermedicalscience Special Issue: Fertility sparing
Advances in haemato-oncology: Expert panel discussion